From March 17, all outbound Scoot passengers flying from Singapore, Indonesia and Hong Kong will be able to book Covid-19 pre-departure RT-PCR and serology tests as part of a trial service run by Collinson.
The service builds upon the pilot recently launched for Singapore Airlines, Scoot’s parent company.
The Collinson online portal, accessible via the Scoot website or mobile app, will allow passengers departing on flights to book pre-departure testing appointments with recognised and accredited partner clinics and digitally receive results within 36 hours.
Passengers will receive their serology test results directly from the clinic. However, RT-PCR test results can be obtained through the portal, with QR codes embedded within the RT-PCR result certificates, enabling digital authentication, streamlining verification and strengthening the integrity of the process.
There are plans to expand the service to other destinations in the Scoot network post-trial.
A digital verification solution from Affinidi, a Temasek-founded technology company, is also being trialled by Scoot at check-in for selected flights from Singapore, Malaysia, and Indonesia. By scanning the QR code with a secure app, check-in agents are able to quickly and reliably determine the authenticity of digital or printed Covid-19 test results bearing a verifiable QR code, issued by selected clinics. This will reduce the check-in time for passengers, thereby, improving their travel experience.
Todd Handcock, president, Asia Pacific, Collinson, said: “Helping to reopen key routes for travellers in a safe way is our utmost priority and this partnership is another step forward in our aim of achieving the long-term return of global travel.”
Campbell Wilson, Scoot CEO, added: “Through both solutions, we hope our customers can be assured of a more convenient, efficient and reliable experience when they travel with us.”
